[1]
C. Crane, “The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities”, J Pharm Pharm Sci, vol. 22, no. 1, pp. 486–500, Aug. 2020.